Skip to content
10-Q

Quarterly Report

Aclaris Therapeutics, Inc. ACRS

0001104659-25-107788

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 108.35M sh
Shares Diluted Q3 2025 · Sep 30, 2025 122.62M sh
Shares Diluted Q3 2025 · Sep 30, 2025 122.53M sh
Shares Diluted Q3 2025 · Sep 30, 2024 71.38M sh
Shares Diluted Q3 2025 · Sep 30, 2024 71.25M sh
Capex Q3 2025 · Sep 30, 2025 $87K
Capex Q3 2025 · Sep 30, 2024 $121K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$33.98M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$11.14M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $25.26M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $24.57M
Stockholders Equity Q3 2025 · Sep 30, 2025 $120.1M
Stockholders Equity Q3 2025 · Jun 30, 2025 $131.74M
Stockholders Equity Q3 2025 · Mar 31, 2025 $144.07M
Stockholders Equity Q3 2025 · Dec 31, 2024 $155.55M
Stockholders Equity Q3 2025 · Sep 30, 2024 $130.15M
Stockholders Equity Q3 2025 · Jun 30, 2024 $133.82M
Stockholders Equity Q3 2025 · Mar 31, 2024 $142.01M
Stockholders Equity Q3 2025 · Dec 31, 2023 $157.18M
Current Liabilities Q3 2025 · Sep 30, 2025 $25.63M
Current Liabilities Q3 2025 · Dec 31, 2024 $31.6M
Total Liabilities Q3 2025 · Sep 30, 2025 $55.43M
Total Liabilities Q3 2025 · Dec 31, 2024 $64.77M
Current Assets Q3 2025 · Sep 30, 2025 $100.59M
Current Assets Q3 2025 · Dec 31, 2024 $125.95M
Total Assets Q3 2025 · Sep 30, 2025 $175.53M
Total Assets Q3 2025 · Dec 31, 2024 $220.33M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.12
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.37
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.11
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.50
Eps Basic Q3 2025 · Sep 30, 2025 −$0.12
Eps Basic Q3 2025 · Sep 30, 2025 −$0.37
Eps Basic Q3 2025 · Sep 30, 2024 −$0.11
Eps Basic Q3 2025 · Sep 30, 2024 −$0.50
Sga Expense Q3 2025 · Sep 30, 2025 $4.87M
Sga Expense Q3 2025 · Sep 30, 2025 $16.4M
Sga Expense Q3 2025 · Sep 30, 2024 $5.65M
Sga Expense Q3 2025 · Sep 30, 2024 $17.25M
Rd Expense Q3 2025 · Sep 30, 2025 $13.03M
Rd Expense Q3 2025 · Sep 30, 2025 $36.06M
Rd Expense Q3 2025 · Sep 30, 2024 $5.96M
Rd Expense Q3 2025 · Sep 30, 2024 $24.56M
Net Income Q3 2025 · Sep 30, 2025 −$14.61M
Net Income Q3 2025 · Sep 30, 2025 −$45.13M
Net Income Q3 2025 · Jun 30, 2025 −$15.43M
Net Income Q3 2025 · Mar 31, 2025 −$15.09M
Net Income Q3 2025 · Sep 30, 2024 −$7.59M
Net Income Q3 2025 · Sep 30, 2024 −$35.51M
Net Income Q3 2025 · Jun 30, 2024 −$10.99M
Net Income Q3 2025 · Mar 31, 2024 −$16.94M
Operating Income Q3 2025 · Sep 30, 2025 −$17.15M
Operating Income Q3 2025 · Sep 30, 2025 −$53.64M
Operating Income Q3 2025 · Sep 30, 2024 −$10.47M
Operating Income Q3 2025 · Sep 30, 2024 −$42.26M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $538K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.56M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $654K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $2.09M
Revenue Q3 2025 · Sep 30, 2025 $3.3M
Revenue Q3 2025 · Sep 30, 2025 $6.53M
Revenue Q3 2025 · Sep 30, 2024 $4.35M
Revenue Q3 2025 · Sep 30, 2024 $9.51M